MedPath

ORNADE EXPECTORANT COUGH FORMULA

ORNADE EXPECTORANT COUGH FORMULA

Discontinued
DIN Number

02067625

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

smithkline beecham consumer healthcare, division of smithkline beecham inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02067625
AIG Number0308905001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05CA10 COMBINATIONS
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification48:16.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

CHLORPHENIRAMINE MALEATEActive
Strength: 2 MG / 5 ML
Monograph: CHLORPHENIRAMINE MALEATE
GUAIFENESINActive
Strength: 100 MG / 5 ML
Monograph: GUAIFENESIN
PHENYLPROPANOLAMINE HYDROCHLORIDEActive
Strength: 15 MG / 5 ML
Monograph: PHENYLPROPANOLAMINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.